| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.62B | +18.6% |
| R&D Expense | $80.0M | +18.2% |
| SG&A Expense | $75.1M | +16.8% |
| Operating Income | -$196.0M | +32.3% |
| Pre-tax Income | -$177.1M | +39.8% |
| Income Tax | $659K | +175.0% |
| Net Income | -$172.3M | +40.1% |
| EPS (Basic) | -$0.54 | +48.1% |
| EPS (Diluted) | -$0.54 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $161.4M | -34.2% |
| Accounts Receivable | $71.1M | -11.5% |
| Current Assets | $274.0M | -29.1% |
| Total Assets | $1.08B | -12.6% |
| Current Liabilities | $515.3M | -0.4% |
| Total Liabilities | $896.6M | -5.5% |
| Stockholders' Equity | $180.8M | -36.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$79.5M | +55.3% |
| Capital Expenditures | $2.7M | +154.6% |
| Investing Cash Flow | -$15.8M | +37.7% |
| Financing Cash Flow | $11.5M | -89.7% |
| Free Cash Flow | -$82.2M | +54.0% |
| +48.1% |